281652-10-6

Basic information

• Product Name: tert-butyl 4,4-difluoropiperidine-1-carboxylate
• Synonyms: tert-Butyl 4,4-difluoro-1-piperidinecarboxylate;tert-butyl 4,4-difluoropiperidine-1-carboxylate;4,4-Difluoro-piperidine-1-carboxylic acid tert-butyl ester
• CAS NO: 281652-10-6
• Molecular Formula: C10H17F2NO2
• Molecular Weight: 221.2442864
• Mol File: 281652-10-6.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 247.7±40.0 °C(Predicted)
• Appearance: /
• Density: 1.12±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: -4.70±0.40(Predicted)
• CAS DataBase Reference: tert-butyl 4,4-difluoropiperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4,4-difluoropiperidine-1-carboxylate(281652-10-6)
• EPA Substance Registry System: tert-butyl 4,4-difluoropiperidine-1-carboxylate(281652-10-6)

Safety Data

• Hazardous Substances Data: 281652-10-6(Hazardous Substances Data)

Usage

General Description

"Tert-butyl 4,4-difluoropiperidine-1-carboxylate" is a chemical compound with a molecular formula C11H18F2N2O2. It is a fluorinated piperidine derivative that is commonly used in the pharmaceutical and agrochemical industries. tert-butyl 4,4-difluoropiperidine-1-carboxylate is known for its potential medicinal properties and is being studied for its use as a building block in the synthesis of various biologically active compounds. Tert-butyl 4,4-difluoropiperidine-1-carboxylate may also have applications in the development of new drugs and agrochemicals, making it an important compound in the field of medicinal and agricultural chemistry.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 41979-39-9 4-piperidone hydrochloride 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 190906-92-4 tert-butyl 2-methyl-4-oxopiperidine-1-carboxylate 
• 144230-52-4 4,4-difluoropiperidine hydrochloride 
• 281652-40-2 tert-butyl 4-fluoro-3,6-dihydropyridine-1(2H)-carboxylate 

Downstream Products

• 21987-29-1 4,4-difluoropiperidine 
• 1454291-01-0 (RS)(4,4-difluoro-2-(((5-(trifluoromethyl)pyridin-2-yl)amino)methyl)piperidin-1-yl)(3-phenylpyridin-2-yl)methanone 
• 1454290-40-4 (RS)(4,4-difluoro-2-(((5-(trifluoromethyl)pyridin-2-yl)amino)methyl)piperidin-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone 
• 1454290-38-0 (2-(((4,6-dimethylpyrimidin-2-yI)amino)methyl)-4,4-difluoropiperidin-1-yl)(5-methyl-2-(2H-1 ,2,3-triazol-2-yl)phenyl)methanone 
• 1454290-33-5 (2-(((5-chloropyridin-2-yl)amino)methyl)-4,4-difluoropiperidin-1-yl)(2-methyl-5-phenylthiazol-4-yl)methanone 
• 1259011-99-8 (±) tert-butyl 2-(aminomethyl)-4,4-difluoropiperidine-1-carboxylate 
• 1454290-70-0 (RS)(2-(benzyloxy)phenyl)(2-(((5-chloropyridin-2-yl)amino)methyl)-4,4-difluoropiperidin-1-yl)methanone 
• 144230-52-4 4,4-difluoropiperidine hydrochloride 

Relevant articles and documents

TRPML MODULATORS

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

C-3 NOVEL TRITERPENONE WITH C-28 AMIDE DERIVATIVES AS HIV INHIBITORS

The invention relates to C-3 novel triterpenone with C-28 amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases (formula 1).

NOVEL BETULINIC SUBSTITUTED AMIDE DERIVATIVES AS HIV INHIBITORS

The present invention relates to novel betulinic substituted amide compounds of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, X, Y, Z1, Z2, Z3 and are Formula (II) as defined herein. The invention novel betulinic substituted amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.